TrialSafety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT05521438
- Phase
- Phase 2, Phase 3
QNRX
Quoin Pharmaceuticals
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
4Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Active not recruiting | 2025-12-30Actual |
| Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT05789056 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2026-12-30Estimated |
| Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT06953466 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2026-12-30Estimated |
| Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT07538583 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2027-01-31Estimated |
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT05789056
- Phase
- Phase 2, Phase 3
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT06953466
- Phase
- Phase 2, Phase 3
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT07538583
- Phase
- Phase 2, Phase 3
Latest recorded trial changes
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT06953466 · Quoin Pharmaceuticals
Primary completion date changed
− Before
30 Jul 2026
+ After
30 Dec 2026
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05789056 · Quoin Pharmaceuticals
Primary completion date changed
− Before
30 Dec 2025
+ After
30 Dec 2026
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05521438 · Quoin Pharmaceuticals
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
31 Dec 2025
+ After
30 Dec 2025
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05521438 · Quoin Pharmaceuticals
Recruitment status changed
− Before
Recruiting
+ After
Active not recruiting